Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X

Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta bloc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Iran J Pharm Res
Autori principali: Majidinia, Maryam, Rasmi, Yousef, Khadem Ansari, Mohammad Hassan, Seyed-Mohammadzad, MirHossein, Saboory, Ehsan, Shirpoor, Alireza
Natura: Artigo
Lingua:Inglês
Pubblicazione: Shaheed Beheshti University of Medical Sciences 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5149044/
https://ncbi.nlm.nih.gov/pubmed/27980592
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi